WO2003080025A1 - Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes - Google Patents
Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes Download PDFInfo
- Publication number
- WO2003080025A1 WO2003080025A1 PCT/FR2003/000948 FR0300948W WO03080025A1 WO 2003080025 A1 WO2003080025 A1 WO 2003080025A1 FR 0300948 W FR0300948 W FR 0300948W WO 03080025 A1 WO03080025 A1 WO 03080025A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topical composition
- composition according
- erythemas
- exchange resins
- ion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Definitions
- the present invention relates to a topical composition based on ion exchange resins such as colestyramine, in particular for the treatment of diaper rash in pediatrics.
- Acute diarrhea which affects many children, especially children under the age of five, often requires treatment to avoid secondary infections and to relieve children of the pain and itching it causes.
- these bile salts which are acids lower the skin pH and induce erythema.
- these bile salts have surface-active properties, so that the layer of sebum which is naturally protective, is eliminated.
- colestyramine is a basic synthetic anion exchange resin which has a strong affinity for bile salts and forms with them an insoluble complex.
- 1 gram of colestyramine can absorb up to two grams of bile salts. It is a fine white hygroscopic powder, almost insoluble in water, alcohol, chloroform and ether. In a 1% solution, the pH is between 4 and 6.
- the present invention relates to a composition including at least one ion exchange resin, in particular colestyramine as well as a pH regulator. Indeed, in a completely relevant way, the regulator makes it possible to increase the pH to allow an optimized absorption of bile salts by ion exchange resins.
- a basic composition according to the present invention comprises the following elements:
- This composition results in a thick paste.
- Trials are conducted on subjects with secondary dermatitis as a condition
- the thick colestyramine paste is applied 4 times a day to the area corresponding substantially to the area covered by a diaper.
- the medical observation is conducted for each application.
- a regression of the lesions is noted after 2 to 7 days.
- the composition allows a local physiological rebalancing following the appearance of irritant dermatitis.
- the pH regulators can also be chosen from: monopotassium phosphate, disodium phosphate, sodium acetate, ammonium acetate, sodium citrate, citric acid, disodium tetraborate, boric acid , amino acids like lysine, leucine, alanine, methyl p ⁇ r ⁇ hydroxybenzo ⁇ te, propyl p ⁇ r ⁇ hydroxybenzo ⁇ te, sodium benzo ⁇ te.
- galenical formulations in the form of creams or talc are given below.
- Labraf il trade name of oleic macrogolglycerides
- Tefose 63 trade name of PEG-6-32 Stearate and glycol stearate. / Cream with 10% colestyramine and sodium dihydrogen phosphate
- composition can also be considered for application directly to external supports in direct contact with the areas to be treated, such as diapers for infants, children and the elderly.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/509,388 US20050220755A1 (en) | 2002-03-26 | 2003-03-26 | Topical composition based on ion-exchange resins, in particular for treating erythemas |
CA002480007A CA2480007A1 (fr) | 2002-03-26 | 2003-03-26 | Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes |
AU2003244715A AU2003244715A1 (en) | 2002-03-26 | 2003-03-26 | Topical composition based on ion-exchange resins, in particular for treating erythemas |
EP03738198A EP1487408A1 (fr) | 2002-03-26 | 2003-03-26 | Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR02/03729 | 2002-03-26 | ||
FR0203729A FR2837710B1 (fr) | 2002-03-26 | 2002-03-26 | Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003080025A1 true WO2003080025A1 (fr) | 2003-10-02 |
Family
ID=27839185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2003/000948 WO2003080025A1 (fr) | 2002-03-26 | 2003-03-26 | Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050220755A1 (fr) |
EP (1) | EP1487408A1 (fr) |
AU (1) | AU2003244715A1 (fr) |
CA (1) | CA2480007A1 (fr) |
FR (1) | FR2837710B1 (fr) |
WO (1) | WO2003080025A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2947276B1 (fr) * | 2009-06-24 | 2012-10-26 | Seppic Sa | Composition cosmetique a base de resines echangeuses d'ions chargees avec des lipoaminoacides |
DE102022103062A1 (de) * | 2022-02-09 | 2023-08-10 | Dietrich Seidel | Produkte zur Bakterientoxinbindung und -Elimination bei der Behandlung von Wunden und entzündlichen Hautveränderungen |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2919230A (en) * | 1953-10-29 | 1959-12-29 | Rohm & Haas | Hydrophilic base therapeutic compositions comprising cation-exchange resin |
WO2000018316A2 (fr) * | 1998-09-25 | 2000-04-06 | Alcon Laboratories, Inc. | Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire |
WO2001021209A1 (fr) * | 1999-09-21 | 2001-03-29 | Alcon Laboratories, Inc. | Utilisation de savons d'acide gras ou d'acide amine pour ameliorer l'efficacite anti-microbienne de compositions pharmaceutiques topiques |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851392A (en) * | 1985-02-05 | 1989-07-25 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
ATE180968T1 (de) * | 1991-12-20 | 1999-06-15 | Hoechst Ag | Polyaspartamidderivate als adsorptionsmittel für gallensäuren, mit gallensäuren beladene polyaspartamidderivate und verfahren zu deren herstellung sowie deren anwendung als arzneimittel |
-
2002
- 2002-03-26 FR FR0203729A patent/FR2837710B1/fr not_active Expired - Fee Related
-
2003
- 2003-03-26 CA CA002480007A patent/CA2480007A1/fr not_active Abandoned
- 2003-03-26 US US10/509,388 patent/US20050220755A1/en not_active Abandoned
- 2003-03-26 EP EP03738198A patent/EP1487408A1/fr not_active Withdrawn
- 2003-03-26 AU AU2003244715A patent/AU2003244715A1/en not_active Abandoned
- 2003-03-26 WO PCT/FR2003/000948 patent/WO2003080025A1/fr not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2919230A (en) * | 1953-10-29 | 1959-12-29 | Rohm & Haas | Hydrophilic base therapeutic compositions comprising cation-exchange resin |
WO2000018316A2 (fr) * | 1998-09-25 | 2000-04-06 | Alcon Laboratories, Inc. | Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire |
WO2001021209A1 (fr) * | 1999-09-21 | 2001-03-29 | Alcon Laboratories, Inc. | Utilisation de savons d'acide gras ou d'acide amine pour ameliorer l'efficacite anti-microbienne de compositions pharmaceutiques topiques |
Also Published As
Publication number | Publication date |
---|---|
AU2003244715A1 (en) | 2003-10-08 |
EP1487408A1 (fr) | 2004-12-22 |
FR2837710A1 (fr) | 2003-10-03 |
FR2837710B1 (fr) | 2005-07-08 |
US20050220755A1 (en) | 2005-10-06 |
CA2480007A1 (fr) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230240984A1 (en) | Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis | |
WO2008140200A1 (fr) | Compositions externes pour la peau | |
AU2393701A (en) | Pharmaceutical and cosmetic carrier or composition for topical application | |
JP2012517989A (ja) | 皮膚疾患を治療または予防するための、アベルメクチンまたはミルベマイシンとアドレナリン受容体との組合せ | |
US20140154342A1 (en) | Sandalwood oil and its uses related to skin disorders | |
GB1594314A (en) | Medicine for the treatment of acne | |
US5674539A (en) | Method of treating skin and composition | |
FR2460135A1 (fr) | Composition a usage externe a base de colostrum | |
CA2533591A1 (fr) | Methode de traitement de plaies et de lesions de la peau | |
EP1032378B1 (fr) | Utilisation d'un melange de diol et d'acide alpha-hydroxyle pour traiter des hyperkeratoses | |
WO2003080025A1 (fr) | Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes | |
JP2003089629A (ja) | 新規化粧品、新規外用剤及び新規浴剤の製造方法 | |
FR2894820A1 (fr) | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations | |
CA2120345A1 (fr) | Gel mucoadhesif vaginal, medicament le contenant et procede de preparation dudit gel | |
FR2646603A1 (fr) | Composition nettoyante | |
FR2793795B1 (fr) | Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale | |
EP1965786B1 (fr) | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations | |
EP0075523A1 (fr) | Nouveaux médicaments à base d'extraits d'algues, et formulations correspondantes | |
JP2024509309A (ja) | 三環式ヘテロアリール基を有する化合物の用途 | |
FR2558058A1 (fr) | Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne | |
FR2694694A1 (fr) | Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu. | |
McKinnon et al. | Calcipotriol (Dovonex) scalp solution in the treatment of scalp psoriasis: comparative efficacy with 1% coal tar/1% coconut oil/0.5% salicylic acid (Capasal) shampoo, and long-term experience | |
Jasmin et al. | Assessment of the efficacy of a 3% chlorhexidine shampoo in the control of elevated cutaneous Malassezia populations and associated clinical signs (Malassezia dermatitis) in dogs | |
US20060222712A1 (en) | Acne gel | |
US11318090B1 (en) | In situ gelling composition as a pH-selective and mucoadhesive sustained release drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003738198 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2480007 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10509388 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003738198 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003738198 Country of ref document: EP |